Document is current
Any future updates will be listed below
-
Authors
Tsoi, Alexander https://orcid.org/0009-0004-4815-7477
Gomez, Alvaro https://orcid.org/0000-0001-9618-1755
Boström, Carina https://orcid.org/0000-0002-2506-687X
Pezzella, Denise
Chow, Jun Weng
Girard-Guyonvarc’h, Charlotte https://orcid.org/0000-0002-4901-2059
Stamm, Tanja https://orcid.org/0000-0003-3073-7284
Arnaud, Laurent https://orcid.org/0000-0002-8077-8394
Parodis, Ioannis https://orcid.org/0000-0002-4875-5395
-
Funding
Funding for this research was provided by:
Stiftelsen Konung Gustaf V:s 80-årsfond (FAI-2020-0741)
Swedish Rheumatism Association (R-969696)
Nyckelfonden (OLL-974804)
Swedish society of medicine (SLS-974449)
Stiftelsen Professor Nanna Svartz Fond (2021-00435)
Karolinska Institutet
Region Stockholm (FoUI-955483)
Ulla and Roland Gustafsson Foundation (2021 - 26)
Norrbacka-Eugeniastiftelsen
Karolinska Institute
- License Information
-
More Information
Article History
Received: 27 November 2023
Accepted: 24 January 2024
First Online: 7 March 2024
Declarations
:
: IP has received research funding and/or honoraria from Amgen, AstraZeneca, Aurinia, Bristol-Myers Squibb, Elli Lilly, Gilead, GlaxoSmithKline, Janssen, Novartis, Otsuka, and Roche. All other authors declare that they have no conflicts of interest. The funders had no role in the design of the study, in the collection, analyses, or interpretation of data, in the writing of the manuscript, or in the decision to publish the results.
